Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MethOxyflUraNe at moderaTe High AltItudes for PAIN Management: A Randomised, Double-blind, Cross-over Study

NCT03849027 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT03849027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03849027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MethOxyflUraNe at moderaTe High AltItudes for PAIN Management: A Randomised, Double-blind, Cross-over Study
Lead sponsor
University of Cape Town
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2019
Completion date
December 31, 2019
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain